Nomura Holdings Inc Intercept Pharmaceuticals, Inc. Put Options Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $2.27 Million - $4.43 Million	-117,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $2.14 Million - $3.71 Million	87,300 Added 291.0%	117,300 $2.9 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $1.17 Million - $1.61 Million	-20,000 Reduced 40.0%	30,000 $1.98 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $3.89 Million - $6.03 Million	50,000 New	50,000 $0

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.